Product Description:

• REYATAZ is a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 3 months and older weighing at least 5 kg.

How to use:

• Treatment-naive adults:REYATAZ 300 mg with ritonavir 100 mg once daily with food or REYATAZ 400 mg once daily with food.


• Treatment-experienced adults:REYATAZ 300 mg with ritonavir 100 mg once daily with food.


• Pediatric patients:REYATAZ capsule dosage is based on body weight not to exceed the adult dose and must be taken with food.

Caution & Warnings:

• Cardiac conduction abnormalities


• Severe Skin Reactions


• Phenylketonuria


• Hepatotoxicity


• Chronic kidney disease


• Nephrolithiasis and cholelithiasis

Side Effects:

• Nausea, jaundice/scleral icterus, rash, headache, abdominal pain, vomiting, insomnia, peripheral neurologic symptoms, dizziness, myalgia, diarrhea, depression, and fever.

Ingredients:

• Atazanavir 200Mg.